相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
Emily K. Sims et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Children, 2010-2017
G. Todd Alonso et al.
DIABETES CARE (2020)
Lessons From Continuous Glucose Monitoring in Youth With Pre-Type 1 Diabetes, Obesity, and Cystic Fibrosis
Christine L. Chan et al.
DIABETES CARE (2020)
Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany
Anette-Gabriele Ziegler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado
R. Brett McQueen et al.
DIABETES CARE (2020)
Parental anxiety after 5 years of participation in a longitudinal study of children at high risk of type 1 diabetes
Jessica Melin et al.
PEDIATRIC DIABETES (2020)
One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes
Kimber M. Simmons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Continuous Glucose Monitoring Predicts Progression to Diabetes in Autoantibody Positive Children
Andrea K. Steck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Predicting progression to diabetes in islet autoantibody positive children
Andrea K. Steck et al.
JOURNAL OF AUTOIMMUNITY (2018)
Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful?
Laura B. Smith et al.
PEDIATRIC DIABETES (2018)
ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents
Jennifer J. Couper et al.
PEDIATRIC DIABETES (2018)
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials
Brandon M. Nathan et al.
DIABETES CARE (2017)
My Child Is Islet Autoantibody Positive: Impact on Parental Anxiety
Suzanne Bennett Johnson et al.
DIABETES CARE (2017)
Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control
Lindsey M. Duca et al.
DIABETES CARE (2017)
Continuous glucose monitoring and HbA1c in the evaluation of glucose metabolism in children at high risk for type 1 diabetes mellitus
Olli Helminen et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2016)
Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study
Jennifer Raab et al.
BMJ OPEN (2016)
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel et al.
DIABETES CARE (2015)
Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes
Annelien Van Dalem et al.
DIABETOLOGIA (2015)
Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes
Andrea K. Steck et al.
DIABETES CARE (2014)
Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease
Helena Elding Larsson et al.
PEDIATRIC DIABETES (2014)
GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
Dongmei Miao et al.
DIABETES (2013)
The use of intermediate endpoints in the design of type 1 diabetes prevention trials
Jeffrey P. Krischer
DIABETOLOGIA (2013)
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
Anette G. Ziegler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Distinguishing Persistent Insulin Autoantibodies With Differential Risk Nonradioactive Bivalent Proinsulin/Insulin Autoantibody Assay
Liping Yu et al.
DIABETES (2012)
The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial-Type 1
Jay M. Sosenko et al.
DIABETES (2012)
Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth
Kendra Vehik et al.
DIABETES CARE (2012)
The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes
Jay M. Sosenko et al.
DIABETES CARE (2012)
Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population Receiver operating characteristic analysis
Ping Xu et al.
DIABETES CARE (2012)
Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases Consortia
Ezio Bonifacio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial-Type 1
Jay M. Sosenko et al.
DIABETES CARE (2009)
A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type-1
Jay M. Sosenko et al.
DIABETES CARE (2008)
Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes - The Diabetes Prevention Trial-Type 1
Jay M. Sosenko et al.
DIABETES CARE (2007)
Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY)
Lars C. Stene et al.
PEDIATRIC DIABETES (2006)
Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up
JM Barker et al.
DIABETES CARE (2004)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
分享论文
